Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

INTRODUCTION: Loss of HBeAg and development of anti-HBe (seroconversion) is seen as a milestone and endpoint in the treatment of HBeAg-positive patients with chronic hepatitis B (CHB). Among patients treated with nucleos (t)ide analogs (NA), recurrent viremia is common after discontinuation of thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dig Dis Sci
Main Authors: Fong, Tse-Ling, Tien, Andy, Jo, Kahee J., Chu, Danny, Cheung, Eddie, Mena, Edward A., Phan, Quang-Quoc, Yu, Andy S., Mohammed, Wafa, Velasco, Andrew, LeDuc, Vinh-Huy, Nguyen, Nickolas, Han, Steven-Bui, Chang, Mimi, Bae, Ho S., Cho, Yong-Won, Tong, Myron J., Cooper, Stewart L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4803449/
https://ncbi.nlm.nih.gov/pubmed/26138653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-015-3775-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados